pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-6132 |
Genomic Coordinates | chr7: 117020211 - 117020319 |
Description | Homo sapiens miR-6132 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-6132 | |||||||||||||||
Sequence | 21| AGCAGGGCUGGGGAUUGCA |39 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | |||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CLASP1 | ||||||||||||||||||||
Synonyms | MAST1 | ||||||||||||||||||||
Description | cytoplasmic linker associated protein 1 | ||||||||||||||||||||
Transcript | NM_001142273 | ||||||||||||||||||||
Other Transcripts | NM_001142274 , NM_015282 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CLASP1 | |||||||||||||||||||||
3'UTR of CLASP1 (miRNA target sites are highlighted) |
>CLASP1|NM_001142273|3'UTR 1 TGGCAGTACCTGTCTCTTGTGTAGACCTAGAAGCAATCGGTGGTGCCTCTCAGAGACCTTTCCCCACCCCCTTCATCGGC 81 TGCCCAGTCAGTACAAGGAGGCCCACAAATATTTATTACAATCAGTATTTTGGTCCCTTCCAGCTTTTCTGTAGAATCTT 161 ACTGGTATTGAATGTAAAGGAAGCAAGGCCTGTATTGCAGTCTTCATACAAAACAAAAGGAATAAGAACAGAAAAGAGCC 241 ATACTGAAACATGTCTTGTACAGCCTGCTGAGATGGCGAAACCCTGTGTGTGGGGTGCAGTTTTTAAAAATCAGAGCGCT 321 CTAGCCACTACTTGGTAGAAAGTAGCATTTTTTTTTTCAGTTAATAACATATTTGGGGGTGGGGTGGGGTGTTACTTTGT 401 GTTCTTCCTCCTTAGCCTATTTTCTTGTGCGTATGGTCTGTGTGGGGCCCCTTTCACAGCTGACACCACGAAAGGTGATA 481 TATCTTTAAGTTGTGTTCTGAGACCTACTAAAAATGGGAATCAAGTCTTGGCAAGAACAGTCTGAAGATGGCCTTTTAAC 561 AAACGCTGGGAATTTTGCTTGTCATATCCAGACTGGAGGCCGACTGCCCTGGCTTTCAGCGTAGAATTGGGAGTGCACCC 641 TGACAGTCTCCTTCCAGCTCTCCCTAATCGACTCCACCGACAAGGTCCCTACCCCAGAGCTTCCATGCAAAGGAATTCTT 721 CAAGTTTAAATCTGGACACAAAAATAAGATAAATGTATGGCATCATTTAGGGATGCCTGAGATGGCAGTTCATGAAGCAC 801 AGAAGATAAAGAAGAAGTCTTTCATCTTTACTGCTGAGATCCTTGGGAACACTGTTGTCATGGGGGCTCTGCCAAGACCC 881 TCATCTCTGGGCTACACGGTGATTCAGATTGAGCACCAACTTGTTTCCTCCCCTCAAAGTTCTGCCTAAGCCGTTCAGTT 961 CTAACATGGTCTCAGTTAATCTGGTAAATGGCATCTTTACCATCTTAGTTCTGACTTCTCAGTTTAATGTGGGATTAAGA 1041 GCCAAGAAAAGCCTAGAGAGACTGGATATCACAATTTTTTTTAATTTTATAAACTGAAGTAGTTCCTTGAATGTCTGTTG 1121 ATGAAATAGTCACTGTTTAAGGAAAAAAGTAATTATGAGGTGTAGCAGATTGCAGAAAAACAGGATTAGAAACACACTTA 1201 AAAAGAACACACATTTAGAGTCTCTCTTCCTCCTCAGCGAACCACTAGGCCCCCTTTTTAAAAACACCTTTAGAGCCTAA 1281 TTACTCCAATAAAAGTAACTAGAGGTTTGGAGTCTGGTTAAATAAATTCTGAGTAAAATTCTTAAGCCAAATGGAAATTC 1361 TTAATGCAATCATGAGGACTTCTATTGTCTCTTACTGTTGTATTAGATCCTATAAATTGAACTGATTTTTCCATAAGGAA 1441 AATGCTTCTTTTGAGATTAATTCTAATAACGTATTTGCTATTGCAGTGCAGAGCCCACTGCAACTGCTAGGACTGAAAGC 1521 AGAGGCTGGGTGCCAGAGCACGTGATTCTTAACATCATTTCCACAGACCCCTCTGCCCTGACCCTCTGCATTGGATGCAG 1601 GAAGCTGGGAAAGACTGATGTTGATTTGGAAACATGGGCTGAAAATGAAGGCCCCATAGTGCATAGGAACAGTAAAGCCA 1681 GGGTGCTGACGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGGTGTTGTGTGTGTTTGTGCGTGCACCCTACA 1761 CATGTGTGGTACCTCACTGCTGCTGTTTAGGGAACTTGAGGGACGCGTTTCAAGGGGTTGGGTATTACTGACGAGCTTTG 1841 GCTCAAAATATAGCAGGACCAGGTCTTTTGTTGATAAGTACTGTTTGTTTATTAATATGTCATTAATGGTATTTCTTTTT 1921 TACACTCTACAAGTGAATTAGGGAGTCTCTTGTTGACCCCTTTGTTGCAGGAATGTGCGTCGGGCTAGGTTATCCATGAG 2001 TTTCTTTATTCCTAATGCAGTTAGAAAGACCTTTCTCCTTGAGCTCTTTGACTCCCAGAAGGTACCCCAGTCCCCAGTGT 2081 ACTTAGAAAGGATCTCGAACATTGCTGGACGTCCTCATAGTACTCACAAAGGGCTAGCCTTGAATGTCACTCGCCCAGTC 2161 TTCAGTCTCCTGACTTAGAGATACAATCACGTCACAGGTCTCTTGGCCTCAATCTGAAAACTGCTGCCGCCGCGCCGAGG 2241 AGACTCGCATGCCGCCACCACCTCACTGGGAGGGCGCCGAGCCCACCGTCGCCCCCTAGACCCTGACAGCTGCAGCTGCC 2321 TTGCCTTGCCGCCGCCTCCCTGCAGGGCCCCTGTTCCAATGAAAAACAGAACACAAAAGAGCAGAGCACCTAAGCCTGTC 2401 TCTGCCTCCCTGTCTACCGGACTGGCCAGGGCCCAAGACCCCCGCTGCTCCACTGCGGGGCTGGGCGGGCTGACTCCCTG 2481 CTTCCTCCAAGCTGCTGCCTCCCCTGCAGCCAGGGTCTGGGCAGGGTGCAGCCGGTCCTCGGGGCACGCAGCTTCCTTCA 2561 AGTACACTGTGTGTGCTTCCCGGACCTGCGGCGATGCCACGGGCCTGCCTTTTCTATGCGCCTCACTAGCTTACCACCCT 2641 GTGCAGGTAATGCAACTGACTTTGTCTCATCAGTCTTTTTCTTTCCCTGCCACCCTTTATTTATCAAGCGTAATGTTACA 2721 CTTTAAAGGACAGCAAATAAGAACTTTGTAGAATCCCACCAGGACTTTGCTAACAATAATGTTTGGAAATAAAGAAGTGC 2801 TCTGAAAAAATATCAGCCACCAAAATAGTTATGTTGGCACTGTGTTCACACGCATGGTCCCCACACCCCCAGGTTGGGTG 2881 GGTTTTTTTGTTTTTTGGGTTTTTTTGGGGGGGGGGGCTTTTTCATGTTACATCCATATCTGTATTTATATCTTATTTGT 2961 TTCACTTTCAAGTGTATCATGGCAAATGTACAGATTTTTTTGTTAATAATGTGCTAGGATTTGCTAAAAAAGAAAAAAAA 3041 AAAACCCTTTTGAGTTTGCCCTAGAATAAATGAGACTTAATTCAAAAAAAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | C8166 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000409078.3 | 3UTR | GCCUUGCCGCCGCCUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000409078.3 | 3UTR | GCCUUGCCGCCGCCUCCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
82 hsa-miR-6132 Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT067294 | NECAP1 | NECAP endocytosis associated 1 | ![]() |
![]() |
2 | 10 | ||||||
MIRT100110 | ABT1 | activator of basal transcription 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT358583 | CANX | calnexin | ![]() |
![]() |
2 | 2 | ||||||
MIRT445247 | SEMA5A | semaphorin 5A | ![]() |
![]() |
2 | 2 | ||||||
MIRT445764 | CCND3 | cyclin D3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452388 | LY6E | lymphocyte antigen 6 family member E | ![]() |
![]() |
2 | 4 | ||||||
MIRT452829 | FAM131B | family with sequence similarity 131 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT453450 | GLG1 | golgi glycoprotein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455435 | ID3 | inhibitor of DNA binding 3, HLH protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT460629 | IGFBP4 | insulin like growth factor binding protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT461607 | DPH2 | DPH2 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT461989 | PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464258 | VCL | vinculin | ![]() |
![]() |
2 | 2 | ||||||
MIRT465713 | TNFAIP1 | TNF alpha induced protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466475 | TECPR2 | tectonin beta-propeller repeat containing 2 | ![]() |
![]() |
2 | 7 | ||||||
MIRT467119 | SRGAP1 | SLIT-ROBO Rho GTPase activating protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT468299 | SFT2D2 | SFT2 domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT469696 | RAB5B | RAB5B, member RAS oncogene family | ![]() |
![]() |
2 | 8 | ||||||
MIRT469904 | PTRF | caveolae associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT470015 | PTPLB | 3-hydroxyacyl-CoA dehydratase 2 | ![]() |
1 | 1 | |||||||
MIRT471385 | PDPR | pyruvate dehydrogenase phosphatase regulatory subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT471409 | PDP2 | pyruvate dehyrogenase phosphatase catalytic subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT471719 | OTUB1 | OTU deubiquitinase, ubiquitin aldehyde binding 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT473608 | MARK2 | microtubule affinity regulating kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT476328 | GLTSCR1L | BRD4 interacting chromatin remodeling complex associated protein like | ![]() |
![]() |
2 | 2 | ||||||
MIRT479448 | CDK6 | cyclin dependent kinase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT482032 | AMER1 | APC membrane recruitment protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT482360 | AGO2 | argonaute 2, RISC catalytic component | ![]() |
![]() |
2 | 2 | ||||||
MIRT484661 | HOXD3 | homeobox D3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT486828 | NDOR1 | NADPH dependent diflavin oxidoreductase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487069 | CLASP1 | cytoplasmic linker associated protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT487196 | NFASC | neurofascin | ![]() |
![]() |
2 | 4 | ||||||
MIRT487448 | TFAP2B | transcription factor AP-2 beta | ![]() |
![]() |
2 | 4 | ||||||
MIRT487517 | GXYLT2 | glucoside xylosyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487640 | BRSK2 | BR serine/threonine kinase 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT487755 | SKI | SKI proto-oncogene | ![]() |
![]() |
2 | 4 | ||||||
MIRT489944 | CPLX1 | complexin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491101 | MSI1 | musashi RNA binding protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT491181 | LAMA5 | laminin subunit alpha 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492355 | SEMA7A | semaphorin 7A (John Milton Hagen blood group) | ![]() |
![]() |
2 | 2 | ||||||
MIRT493918 | FAM127B | retrotransposon Gag like 8A | ![]() |
![]() |
2 | 4 | ||||||
MIRT493932 | FAM127A | retrotransposon Gag like 8C | ![]() |
![]() |
2 | 4 | ||||||
MIRT494679 | ARID3A | AT-rich interaction domain 3A | ![]() |
![]() |
2 | 2 | ||||||
MIRT494814 | AKAP11 | A-kinase anchoring protein 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT494835 | ADCY9 | adenylate cyclase 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT495455 | PNMAL2 | paraneoplastic Ma antigen family member 8B | ![]() |
![]() |
2 | 2 | ||||||
MIRT496962 | MAP1LC3B | microtubule associated protein 1 light chain 3 beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT526228 | MTRNR2L5 | MT-RNR2-like 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT531028 | TDGF1P3 | teratocarcinoma-derived growth factor 1 pseudogene 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557110 | HOXA3 | homeobox A3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT560514 | POGK | pogo transposable element derived with KRAB domain | ![]() |
![]() |
2 | 2 | ||||||
MIRT567753 | DLC1 | DLC1 Rho GTPase activating protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT569608 | TRIM29 | tripartite motif containing 29 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570242 | CPNE5 | copine 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT572327 | HSPB6 | heat shock protein family B (small) member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT572373 | ATOX1 | antioxidant 1 copper chaperone | ![]() |
![]() |
2 | 2 | ||||||
MIRT575024 | Tecpr2 | tectonin beta-propeller repeat containing 2 | ![]() |
![]() |
2 | 5 | ||||||
MIRT576146 | Hmox1 | heme oxygenase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT612443 | SMOC2 | SPARC related modular calcium binding 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT615404 | VDAC2 | voltage dependent anion channel 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT629114 | CYCS | cytochrome c, somatic | ![]() |
![]() |
2 | 2 | ||||||
MIRT631362 | FOXI2 | forkhead box I2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT639322 | THBD | thrombomodulin | ![]() |
![]() |
2 | 2 | ||||||
MIRT643797 | ABCC12 | ATP binding cassette subfamily C member 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT669687 | ABLIM1 | actin binding LIM protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT670595 | LLGL1 | LLGL1, scribble cell polarity complex component | ![]() |
![]() |
2 | 4 | ||||||
MIRT691190 | NIF3L1 | NGG1 interacting factor 3 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT691688 | FLOT2 | flotillin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT697127 | OTUD5 | OTU deubiquitinase 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT700814 | PHLDA2 | pleckstrin homology like domain family A member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT701248 | NUP35 | nucleoporin 35 | ![]() |
![]() |
2 | 2 | ||||||
MIRT702362 | KLHL15 | kelch like family member 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT703325 | GDPD5 | glycerophosphodiester phosphodiesterase domain containing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT706060 | PKD1 | polycystin 1, transient receptor potential channel interacting | ![]() |
![]() |
2 | 2 | ||||||
MIRT710475 | CDH5 | cadherin 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713018 | SLC4A2 | solute carrier family 4 member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT716427 | RAB15 | RAB15, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT718093 | ABHD12 | abhydrolase domain containing 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718542 | PIGQ | phosphatidylinositol glycan anchor biosynthesis class Q | ![]() |
![]() |
2 | 2 | ||||||
MIRT719122 | CACFD1 | calcium channel flower domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721393 | LDLRAD4 | low density lipoprotein receptor class A domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT736283 | CDC42 | cell division cycle 42 | ![]() |
![]() |
2 | 0 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|